Clinical Trial Update: High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing high-intensity rosuvastatin versus moderate-intensity rosuvastatin/ezetimibe in patients with high ASCVD risk and type 2 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• rosuvastatin/ezetimibe combination (rosuvastatin/ezetimibe)

Snippet

Sponsor: Yuhan Corporation | Conditions: Atherosclerotic Cardiovascular Disease, Type 2 Diabetes | Phase 4 | Status: UNKNOWN